Free Trial

Guardian Pharmacy Services (NYSE:GRDN) Trading 3.1% Higher - Time to Buy?

Guardian Pharmacy Services logo with Medical background
Remove Ads

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) traded up 3.1% during trading on Monday . The company traded as high as $20.84 and last traded at $20.77. 28,984 shares traded hands during trading, a decline of 82% from the average session volume of 157,247 shares. The stock had previously closed at $20.15.

Guardian Pharmacy Services Stock Performance

The firm's fifty day simple moving average is $20.56.

Institutional Trading of Guardian Pharmacy Services

A number of large investors have recently made changes to their positions in GRDN. Envestnet Asset Management Inc. grew its position in Guardian Pharmacy Services by 4.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company's stock worth $243,000 after acquiring an additional 564 shares in the last quarter. LPL Financial LLC lifted its stake in shares of Guardian Pharmacy Services by 4.8% in the 4th quarter. LPL Financial LLC now owns 17,679 shares of the company's stock valued at $358,000 after purchasing an additional 807 shares during the last quarter. Lazard Asset Management LLC boosted its holdings in shares of Guardian Pharmacy Services by 0.5% in the 4th quarter. Lazard Asset Management LLC now owns 190,797 shares of the company's stock worth $3,865,000 after purchasing an additional 860 shares during the period. R Squared Ltd bought a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at approximately $30,000. Finally, Investment Research & Advisory Group Inc. purchased a new stake in Guardian Pharmacy Services during the 4th quarter valued at $34,000.

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Stories

Remove Ads

Should You Invest $1,000 in Guardian Pharmacy Services Right Now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads